Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Correlation of cognitive impairment and thalamic atrophy in MS: For men only?
Hypovitaminosis-D and EBV: no interdependence between two MS risk factors in a healthy young UK autumn cohort.
Vitamin D and multiple sclerosis: where do we go from here?
Coping strategies and mood profiles in patients with multiple sclerosis.
High and dysregulated secretion of epidermal growth factor from immune cells of patients with relapsing-remitting multiple sclerosis.
Tysabri screening test may be unreliable
Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study.
Transfer of Natalizumab into Breast Milk in a Mother with Multiple Sclerosis.
Natalizumab Discontinuation and Treatment Strategies in Patients with Multiple Sclerosis (MS): A Retrospective Study from Two Italian MS Centers.
CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery.
[Oral disease modifying therapy of multiple sclerosis: the current view.]
Effects of Imatinib Mesylate in Mouse Models of Multiple Sclerosis and In vitro Determinants.
Orally Active 7-Substituted (4-Benzyl-phthalazin-1-yl)-2-methyl-piperazin-1-yl]-nicotinonitriles as Active-site Inhibitors of Sphingosine-1-Phosphate Lyase for the Treatment of Multiple Sclerosis.
Cost analysis of multiple sclerosis in Brazil: a cross-sectional multicenter study.
Levofloxacin-Induced Delirium in a Patient Suffering from Schizoaffective Disorder and Multiple Sclerosis.
Alemtuzumab as Remission Induction Therapy in Behçet Disease: A 20-year Experience.
Oral BG-12 in multiple sclerosis.
Teva and Active Biotech Announce First Patient Enrolled in Phase II Study Evaluating Laquinimod for Primary Progressive MS
White matter atrophy and cognitive dysfunctions in neuromyelitis optica.
Incidence and prevalence of multiple sclerosis in southeastern Iran.
Can PET imaging tell us what's the matter with the gray matter in multiple sclerosis?
Pathogenic features of CD4(+)CD28(-) T cells in immune disorders.
Interleukin-2 and the brain: dissecting central versus peripheral contributions using unique mouse models.
The Ex Vivo Production of IL-6 and IL-21 by CD4(+) T Cells is Directly Associated with Neurological Disability in Neuromyelitis Optica Patients.
Do cortical lesions help us to distinguish MS from NMO?

Pages